FOX vs SER · P/E 13, rev $16.30B vs rev $56.0K
Fox Corp Class B (FOX) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the FOX and SER stock pages for the full models.
Not investment advice.